Eric Weinberg
Insider
First SEC filing: July 29, 2021 · Latest: July 29, 2021
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net: $-14,205
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 15, 2026 | RXST | M | 35,168 | $4.34 | $152,629 | 235,516 Direct | +17.55% | Acquired | 7.8% (price as of 2026-10-02) |
| Sept. 15, 2026 | RXST | M | 35,168 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | D | 87,437 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | D | 95,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | D | 92,200 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | D | 50,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | D | 125,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | A | 65,742 | · | · | 65,742 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | A | 82,608 | · | · | 82,608 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | A | 59,483 | · | · | 59,483 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | A | 32,258 | · | · | 32,258 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 5, 2026 | RXST | A | 93,984 | · | · | 93,984 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2026 | RXST | S | 2,041 | $6.96 | $14,205 | 200,348 Direct | -1.01% | Disposed | -32.8% (price as of 2026-10-02) |
| Aug. 31, 2026 | RXST | M | 5,370 | · | · | 202,389 Direct | +2.73% | Acquired | (price as of 2026-10-02) |
| Aug. 31, 2026 | RXST | M | 5,370 | · | · | 26,848 Direct | -16.67% | Disposed | (price as of 2026-10-02) |
| Feb. 27, 2026 | RXST | A | 32,218 | · | · | 32,218 Direct | · | Acquired | (price as of 2026-10-02) |
| June 2, 2025 | RXST | M | 188,002 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 2, 2025 | RXST | M | 188,002 | $3.93 | $738,848 | 195,351 Direct | +2558.20% | Acquired | 19.1% (price as of 2026-10-02) |
| Feb. 27, 2025 | RXST | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 7, 2024 | RXST | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 4, 2024 | RXST | A | 92,200 | · | · | 92,200 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 1, 2024 | RXST | S 10b5-1 | 10,000 | $50.00 | $500,000 | 299,978 Indirect | -3.23% | Disposed | -90.6% (price as of 2026-10-02) |
| Jan. 22, 2024 | RXST | S 10b5-1 | 10,000 | $48.00 | $480,000 | 309,978 Indirect | -3.13% | Disposed | -90.3% (price as of 2026-10-02) |
| Jan. 9, 2024 | RXST | S 10b5-1 | 10,000 | $46.00 | $460,000 | 319,978 Indirect | -3.03% | Disposed | -89.8% (price as of 2026-10-02) |
| Jan. 8, 2024 | RXST | S 10b5-1 | 10,000 | $42.00 | $420,000 | 329,978 Indirect | -2.94% | Disposed | -88.9% (price as of 2026-10-02) |
| Dec. 22, 2023 | RXST | S 10b5-1 | 1,285 | $40.00 | $51,400 | 339,978 Indirect | -0.38% | Disposed | -88.3% (price as of 2026-10-02) |
| Dec. 15, 2023 | RXST | S 10b5-1 | 8,715 | $40.01 | $348,687 | 341,263 Indirect | -2.49% | Disposed | -88.3% (price as of 2026-10-02) |
| March 9, 2023 | RXST | A | 95,000 | · | · | 95,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 5, 2021 | RXST | P | 9 | $14.90 | $134 | 925 Indirect | +0.98% | Acquired | -68.6% (price as of 2026-10-02) |
| Aug. 4, 2021 | RXST | P | 615 | $16.25 | $9,994 | 916 Indirect | +204.32% | Acquired | -71.2% (price as of 2026-10-02) |
| Aug. 3, 2021 | RXST | P | 1 | $17.03 | $17 | 301 Indirect | +0.33% | Acquired | -72.5% (price as of 2026-10-02) |
| Aug. 3, 2021 | RXST | P | 31,250 | $16.00 | $500,000 | 31,250 Direct | · | Acquired | -70.8% (price as of 2026-10-02) |
| Aug. 2, 2021 | RXST | P | 90 | $17.04 | $1,534 | 300 Indirect | +42.86% | Acquired | -72.5% (price as of 2026-10-02) |
| July 31, 2021 | RXST | A | 87,437 | · | · | 87,437 Direct | · | Acquired | (price as of 2026-10-02) |
| July 30, 2021 | RXST | P | 210 | $16.94 | $3,557 | 210 Indirect | · | Acquired | -72.4% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 15, 2026 | RXST | Stock Option (right to buy) | Common Stock | $4.34 | March 14, 2027 | 35,168 | Disposed |
| Sept. 5, 2026 | RXST | Stock option (right to buy) | Common Stock | $16.00 | July 30, 2031 | 87,437 | Disposed |
| Sept. 5, 2026 | RXST | Stock Option (right to buy) | Common Stock | $14.95 | March 9, 2033 | 95,000 | Disposed |
| Sept. 5, 2026 | RXST | Stock Option (right to buy) | Common Stock | $56.07 | March 3, 2034 | 92,200 | Disposed |
| Sept. 5, 2026 | RXST | Stock Option (right to buy) | Common Stock | $46.24 | Aug. 6, 2034 | 50,000 | Disposed |
| Sept. 5, 2026 | RXST | Stock Option (right to buy) | Common Stock | $28.21 | Feb. 26, 2035 | 125,000 | Disposed |
| Sept. 5, 2026 | RXST | Stock Option (right to buy) | Common Stock | $6.38 | Sept. 4, 2033 | 65,742 | Acquired |
| Sept. 5, 2026 | RXST | Stock Option (right to buy) | Common Stock | $6.38 | Sept. 4, 2033 | 82,608 | Acquired |
| Sept. 5, 2026 | RXST | Stock Option (right to buy) | Common Stock | $6.38 | Sept. 4, 2033 | 59,483 | Acquired |
| Sept. 5, 2026 | RXST | Stock Option (right to buy) | Common Stock | $6.38 | Sept. 4, 2033 | 32,258 | Acquired |
| Sept. 5, 2026 | RXST | Stock Option (right to buy) | Common Stock | $6.38 | Sept. 4, 2033 | 93,984 | Acquired |
| Aug. 31, 2026 | RXST | Restricted Stock Unit | Common Stock | · | · | 5,370 | Disposed |
| Feb. 27, 2026 | RXST | Restricted Stock Unit | Common Stock | · | · | 32,218 | Acquired |
| June 2, 2025 | RXST | Stock Option (right to buy) | Common Stock | $3.93 | July 29, 2025 | 188,002 | Disposed |
| Feb. 27, 2025 | RXST | Stock Option (right to buy) | Common Stock | $28.21 | Feb. 26, 2035 | 125,000 | Acquired |
| Aug. 7, 2024 | RXST | Stock Option (right to buy) | Common Stock | $46.24 | Aug. 6, 2034 | 50,000 | Acquired |
| March 4, 2024 | RXST | Stock Option (right to buy) | Common Stock | $56.07 | March 3, 2034 | 92,200 | Acquired |
| March 9, 2023 | RXST | Stock Option (right to buy) | Common Stock | $14.95 | March 9, 2033 | 95,000 | Acquired |
| July 31, 2021 | RXST | Stock option (right to buy) | Common Stock | $16.00 | July 31, 2031 | 87,437 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 29, 2021 | RXST | Common Stock | 318,728 | Indirect |
| July 29, 2021 | RXST | Stock Option (right to buy) | · | Direct |
| July 29, 2021 | RXST | Stock Option (right to buy) | · | Direct |
| July 29, 2021 | RXST | Stock Option (right to buy) | · | Direct |
| July 29, 2021 | RXST | Stock Option (right to buy) | 72,603 | Direct |
| July 29, 2021 | RXST | Stock Option (right to buy) | 96,805 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $454,167 | · | · | $889,989 | $295,208 | · | $13,364 | $1,652,728 |
| 2022 | $416,667 | · | · | · | $214,042 | · | $8,188 | $638,897 |
| 2021 | $358,798 | $187,500 | · | · | · | · | · | · |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.